Electronic Enthusiast Network Report (Text/Wu Zipeng) For Abbott, many people only know that it is a milk powder brand. In fact, Abbott is a large medical and health company and a century-old enterprise. It ranks 158th in the 2020 Forbes Global 2000 , has more than 100,000 employees worldwide, and its business covers diagnostics, medical devices, nutritional products, pharmaceuticals and other medical and health fields.

During CES 2022, Abbott delivered a speech themed “Personalized Technology Empowers Health: Unleash Your Unlimited Potential”. Individuals can better control their own health conditions and create a common scene and language between patients and doctors. The future has come, the world is changing at an unimaginable speed, and we are creating a new future for you Bring more personalized and precise health solutions with your family.”

Among Abbott’s main products, blood glucose testing and health diagnosis are two of the two businesses, and these two are also necessary technologies for medical wearables. Therefore, at CES 2022, Robert Ford revealed in his speech that Abbott is developing a consumer-grade wearable device solution, named Lingo. According to his introduction, this new device will be able to track the key signals of the human body, allowing consumers to clearly understand their health status at all times, such key information includes glucose, ketones and lactic acid, etc., and then through specific analysis, it can accurately Grasp the health of the human body.

Wearable devices have developed rapidly in recent years. Statistics from market research firm IDC show that the global shipments of wearable devices in 2020 will be 444.7 million units, a year-on-year increase of 28.4%, among which Apple’s device shipments rank first in the market.

An important reason for Apple’s bright data is that the current main battlefield for wearable devices is still in the field of ear-wearing devices. Referring to the statistics for 2020, ear-wearing devices account for 64.2% of the total wearable device shipments. From the perspective of product attributes, the current popular wearable devices are all commercial-grade wearable devices, which have certain physical sign monitoring capabilities but are not outstanding, mainly including exercise volume, heartbeat and breathing.

The current industry consensus is that the follow-up wearable device market will be dominated by professional medical equipment, mainly including monitoring equipment and therapeutic medical equipment, which are used in home, sports and medical scenarios. Citing the forecast data of multiple analysis agencies, the global shipments of wearable devices will exceed 800 million units in 2025, and the proportion of devices such as ear-worn devices and smart watches that perform strongly at this stage will drop to less than half, reaching 388 million Department, professional equipment will contribute more share.

According to Robert Ford, Lingo will not only provide professional glucose, ketone and lactic acid tests, but will also add monitoring of blood alcohol levels in the future. Abbott’s idea is for the wearable to go beyond existing wearables and help users proactively manage their health, nutrition and athletic performance.

From Robert Ford’s speech, we can know that the sensor is a key innovation of Lingo, and Abbott will use a new type of biosensor in the new device, and Abbott is also quite experienced in this regard. In September 2020, Abbott announced that it would use the technology used in its FreeStyle Libre diabetes system to use a new device called the Libre Sense glucose sports biosensor to help athletes monitor their blood sugar levels to meet the Libre launch in Europe in 2020. Sense Glucose Sport Biowearable iii, which is a benchmark applied to CGM-measured glucose levels in healthy individuals.

In December 2020, Health Canada approved Abbott’s next-generation sensor-based blood glucose monitoring technology, FreeStyle Libre 2, for use in adults and children with diabetes aged 4 years and older.

At CES, actress and comedian Sherri Shepherd also showed how FreeStyle Libre 2 changed her life. She only needs to use her smartphone to see her blood sugar status, and it is a unique reading for her. Being able to help her make healthier decisions.

According to statistics from the International Diabetes Federation, the number of people suffering from diabetes worldwide in 2017 was about 425 million, and it is expected to reach 629 million by 2045. Abbott’s professional capabilities in blood glucose testing can help it occupy the market faster and better.

It is reported that Abbott’s FreeStyle Libre has been approved by the Centers for Medicare and Medicaid Services (CMS) in the United States, and has been included in the scope of reimbursement by American medical insurance. Now with FreeStyle Libre 2, Abbott will be able to better help people with diabetes.

Biosensors are instruments that are sensitive to biological substances and convert their concentrations into electrical signals for detection. With the outbreak of wearable devices, biosensors have entered the fast lane of development in recent years, and the product functionality and ease of use will be stronger.

Robert Ford pointed out that in addition to biosensors for measuring human glucose, Abbott is expected to launch other non-glucose detection sensors such as ketones and lactic acid. Adoption, and then enter the general consumer market, has become a key link in smart medical care and telemedicine.

Original title: The latest trend of wearable devices is emerging, which can detect professional indicators such as sugar and ketones

The source of the article: [WeChat public account: Electronic fancier.com] Welcome to add attention! Please indicate the source when the article is reprinted.

Reviewing editor: Tang Zihong

Leave a Reply

Your email address will not be published.